Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03192345
Title A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and REGN2810 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications

melanoma

colorectal adenocarcinoma

Advanced Solid Tumor

Therapies

Cemiplimab + SAR439459

SAR439459

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Investigational Site Number 8400007 Duarte California 91010 United States Details
Investigational Site Number 8400004 Fairway Kansas 66205 United States Details
Investigational Site Number 8400001 Boston Massachusetts 02114 United States Details
Investigational Site Number 8400101 Boston Massachusetts 02115 United States Details
Investigational Site Number 8400008 Durham North Carolina 27710 United States Details
Investigational Site Number 8400006 Nashville Tennessee 37203 United States Details
Investigational Site Number 8400003 Dallas Texas 75230 United States Details
Investigational Site Number 0360002 Heidelberg West 3081 Australia Details
Investigational Site Number 0360001 Melbourne 3000 Australia Details
Investigational Site Number 0560002 Bruxelles 1200 Belgium Details
Investigational Site Number 0560001 Leuven 3000 Belgium Details
Investigational Site Number 1240003 Calgary T2N 4N2 Canada Details
Investigational Site Number 1240002 Montreal H3T 1E2 Canada Details
Investigational Site Number 1240001 Toronto M5G 2M9 Canada Details
Investigational Site Number 2330001 Tallinn 13419 Estonia Details
Investigational Site Number 2500006 Lille 59037 France Details
Investigational Site Number 2500002 Marseille 13385 France Details
Investigational Site Number 2500003 Nantes 44093 France Details
Investigational Site Number 2500005 Nantes 44093 France Details
Investigational Site Number 2500004 Paris 75010 France Details
Investigational Site Number 2500001 Villejuif 94805 France Details
Investigational Site Number 2760001 Essen 45122 Germany Details
Investigational Site Number 2760003 Hannover 30625 Germany Details
Investigational Site Number 3800001 Milano 20133 Italy Details
Investigational Site Number 3800002 Milano 20141 Italy Details
Investigational Site Number 3800003 Rozzano 20089 Italy Details
Investigational Site Number 4100001 Seoul 03080 Korea, Republic of Details
Investigational Site Number 4100002 Seoul 138-736 Korea, Republic of Details
Investigational Site Number 5280001 Rotterdam 3015 GD Netherlands Details
Investigational Site Number 5280002 Utrecht 3584 CX Netherlands Details
Investigational Site Number 7240002 Barcelona 08003 Spain Details
Investigational Site Number 7240001 Barcelona 08035 Spain Details
Investigational Site Number 7240006 Barcelona 08036 Spain Details
Investigational Site Number 7240003 Madrid / Madrid 28040 Spain Details
Investigational Site Number 7240004 Madrid / Madrid 28050 Spain Details
Investigational Site Number 7240005 Pamplona 31008 Spain Details
Investigational Site Number 1580003 Kaohsiung 807 Taiwan Details
Investigational Site Number 1580002 Tainan 704 Taiwan Details
Investigational Site Number 1580001 Taipei 100 Taiwan Details
Investigational Site Number 8260002 Cardiff CF14 2TL United Kingdom Details
Investigational Site Number 8260001 Glasgow G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field